All stock reports

SIMBHALS evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Event Gap Reaction

Evidence unavailable. Direction: LONG.

Tests whether a material opening gap is accepted rather than immediately rejected

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Gap fill and reversal below prior close
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-10-01T23:41:33.263535+00:00

Metrics

latest_annual_period
2026-03-31
revenue
8356682000.0
net_income
-516073000.0
operating_cash_flow
240494000.0
free_cash_flow
211104000.0
total_assets
18483135000.0
total_liabilities
20140919000.0
total_equity
-1748508000.0
cash
842970000.0
total_debt
10107449000.0
revenue_growth
-0.1615569728014865
earnings_growth
-39.96949331722419
net_margin
-0.06175573032454747
roe
0.29515049402118837
debt_to_equity
-5.780613528791404
cash_conversion
-0.4660077159626642
free_cash_flow_margin
0.02526170075635282
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-3f216113c37c7d91b2420413e970583f16b7ae18d569cf117bd9555ead1e04c4
Policy
stock-decisions-v1
Evidence bundle hash
a500e01c26f3b092cadbcb0ab7aab3f06b7e7c10d0a8d82ab226a0b1e193f669
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: f2d3872254f09515395d1957ccbb5a1421ee5c556c6ec18ddc3a8e964fe46191
  • daily-price: 3e5eaf3bfdd4f13010b0d4d50d121cabdab063512597cc2e4bab62f4ea9705c5
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The cached closing price on 2026-10-01 was INR 6.72. The trailing 5-session price return was 8.56%. The trailing 20-session price return was -17.14%. The trailing 60-session price return was 0.30%. The trailing 250-session price return was -52.51%.

Risks

Average cached traded value over twenty sessions was INR 48,865. The closing price was -56.42% below its highest close in the available trailing year. The cached financial metric revenue growth is -0.1615569728014865. The cached financial metric net margin is -0.06175573032454747. The cached financial metric debt to equity is -5.780613528791404. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5.

Follow Up

The cached financial metric cash conversion is -0.4660077159626642. The cached financial metric free cash flow margin is 0.02526170075635282. The cached financial metric latest annual period is 2026-03-31. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-10-01T23:41:33.263535+00:00 from EODHD.

Cached observations and evidence limits